Difference between revisions of "Part:BBa K3610023:Design"
(→Source) |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
| − | + | None | |
| − | + | ||
| − | + | ||
===Source=== | ===Source=== | ||
| − | + | Cyril Zipfel Lab at UZH, Switzerland | |
===References=== | ===References=== | ||
| + | McMahon, Lloyd P.; Choi, Kin M.; Lin, Tai-An; Abraham, Robert T.; Lawrence, John C. (2002): The Rapamycin-Binding Domain Governs Substrate Selectivity by the Mammalian Target of Rapamycin. In: Molecular and Cellular Biology 22 (21), S. 7428. DOI: 10.1128/MCB.22.21.7428-7438.2002. | ||
| + | |||
| + | Inobe T, Nukina N. Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. J Biosci Bioeng. 2016;122(1):40-46. doi:10.1016/j.jbiosc.2015.12.004 | ||
Latest revision as of 23:30, 27 October 2020
FRB
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
None
Source
Cyril Zipfel Lab at UZH, Switzerland
References
McMahon, Lloyd P.; Choi, Kin M.; Lin, Tai-An; Abraham, Robert T.; Lawrence, John C. (2002): The Rapamycin-Binding Domain Governs Substrate Selectivity by the Mammalian Target of Rapamycin. In: Molecular and Cellular Biology 22 (21), S. 7428. DOI: 10.1128/MCB.22.21.7428-7438.2002.
Inobe T, Nukina N. Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. J Biosci Bioeng. 2016;122(1):40-46. doi:10.1016/j.jbiosc.2015.12.004